Drug to Treat Addicts May Help for Cancer


nalproAccording to scientists at St George’s, University of London, a recent study, Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy, published in the International Journal of Oncology,  the drug naltrexone (LDN), which is used to treat addicts may be beneficial for cancer patients if given in low doses.

According to researchers, not only does LDN cause cancer cells to stop growing, it also alters their internal machinery, making them more likely to kill themselves. This discovery could lead to various  other treatments becoming more effective.

The research team was led by Dr Wai Liu and Professor Angus Dalgleish and collaborated on the study with LDN Pharma. The Team discovered that, when used in small doses, the drug can modify the genes that regulate how a cancer cell behaves. LDN can reactivate genes that promote cell killing, as well as modify the genes that interact with the immune system to make it more unfriendly to cancer.

Dr Liu said: “We have shown that the genetic fingerprint of naltrexone differs according to the different doses used, which identifies new ways of using it as an anti-cancer treatment. Rather than stopping the cancer cells from growing, patients want to be rid of them. We saw that by giving the drug for two days, then withdrawing it, cancer cells would stop cycling and undergo cell death.

Dr Liu, who has spent 20 years researching cancer treatment, hopes his research will prompt clinical trials for the use of LDN on cancer patients. He foresees LDN being used in conjunction with other cancer treatments.

At present Naltrexone is licensed in many countries for the treatment of alcohol and heroin addiction, but in much higher doses than tested in this study. While it is not licensed for the treatment of other illnesses, many patients are obtaining it ‘off lable‘ to treat conditions such as Multiple Sclerosis and Fibromyalgia.

Dr Liu added: “We have taken a drug that is relatively safe in humans, and reformulated a new use for it; this has only been possible by understanding the dynamics of a drug. How many other drugs can be improved in this way?

We have shown a similar ‘repackaging’ benefit with the antimalarial drug artesunate and the cannabinoids. In both cases, drugs that are not classically cancer therapies are being trialled as such.

This helps clinicians to devise new ways to tackle a disease that affects so many.”

 

Source:

Article: Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy, Wai M. Liu Katherine A. Scott Jayne L. Dennis Elwira Kaminska Alan J. Levett Angus G. Dalgleish, International Journal of Oncology, doi: 10.3892/ijo.2016.3567, published 7 June 2016.

 

Advertisements

About LFCT

This is a blog about CHILDHOOD CANCER and CHILDHOOD CANCER AWARENESS Little Fighters Cancer Trust is a non-profit organisation that offers support and aid to Children with Cancer and their families. When a child is diagnosed with cancer it affects the whole family. One of the parents, usually the mother, must give up their job to care for the child and this creates financial problems for the family. In South Africa especially the majority of these families are not well-to-do; many of them are rural. A diagnosis of cancer can wipe out any family’s finances, let alone a poor family. The costs of special medications, special diets, hospital stays, transport to and from the hospital or clinic and accommodation and food costs for the mother who spends most of the time at her child’s bedside are astronomical. These are the people and problems that fall through the cracks, and these are the people that Little Fighters Cancer Trust has pledged to help in any way possible. LFCT takes a holistic approach to assisting the Children with Cancer and their Families, with the main aim to be the preservation of individual dignity and pride. Little Fighters Cancer Trust also focuses on promotion and advocacy of National Childhood Cancer Awareness in an effort to increase awareness of Early Warning Signs of Childhood Cancer. This would result in earlier diagnosis, giving the Child with Cancer more of a chance at Treatment and Survival. See "About" for more Background info

Posted on 5 July, 2016, in Blog, Research and tagged , , , , , , , , . Bookmark the permalink. Leave a comment.

Please help us to Raise Childhood Cancer Awareness by Commenting and Sharing

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: